Detalles de la búsqueda
1.
Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study).
BMC Cancer
; 23(1): 1098, 2023 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951905
2.
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
Jpn J Clin Oncol
; 52(7): 725-734, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470391
3.
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Int J Clin Oncol
; 27(9): 1450-1458, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861943
4.
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer.
Cancer Sci
; 112(4): 1567-1578, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548159
5.
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.
Cancer Sci
; 112(1): 314-322, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33075166
6.
Multicenter phase II clinical study of the efficiency and safety of capecitabine plus intermittent oxaliplatin with bevacizumab as first-line therapy in patients with metastatic colorectal cancer (VOICE trial).
Int J Colorectal Dis
; 36(12): 2637-2647, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34368890
7.
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
Int J Clin Oncol
; 26(7): 1238-1247, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33928486
8.
Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer.
Br J Cancer
; 122(8): 1271, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32099097
9.
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.
Br J Cancer
; 123(10): 1490-1495, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32863385
10.
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
Int J Clin Oncol
; 25(4): 614-621, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838590
11.
[Significance of Surgery for Multidisciplinary Treatment Including Neoadjuvant Chemotherapy for Locally Advanced Colorectal Cancer].
Gan To Kagaku Ryoho
; 47(13): 2174-2176, 2020 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-33468898
12.
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.
Cancer Sci
; 110(11): 3565-3572, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31520559
13.
Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer.
Cancer Sci
; 110(3): 1032-1043, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30657223
14.
A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer.
Br J Cancer
; 120(10): 982-986, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31015557
15.
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
Oncologist
; 24(3): 327-337, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30425180
16.
Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial.
Jpn J Clin Oncol
; 49(4): 339-346, 2019 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30753571
17.
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
Oncologist
; 23(1): 7-15, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28894015
18.
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.
Cancer Sci
; 108(10): 2045-2051, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28763145
19.
Cumulative incidence, risk factors and prognostic impact of venous thromboembolism in Japanese patients with advanced gastric cancer.
Jpn J Clin Oncol
; 47(10): 942-948, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28981740
20.
[Utility of Preoperative Chemotherapy for Locally Advanced Colorectal Cancer].
Gan To Kagaku Ryoho
; 44(12): 1296-1298, 2017 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-29394612